Myopia management has advanced significantly over the past decade, and today there are several proven options for slowing the progression of nearsightedness in children. Each approach works through a different mechanism, has its own set of advantages, and suits different ages, lifestyles, and comfort levels. The right choice for your child depends on factors your eye doctor will help you evaluate, including your child's age, current prescription, rate of progression, and daily habits.
According to the National Eye Institute, 42 percent of Americans are now nearsighted, up from 25 percent in the 1970s. That sharp increase has made the development and refinement of myopia control treatments a priority in pediatric eye care worldwide. The good news is that families today have access to multiple evidence-based options, each capable of meaningfully slowing the rate at which a child's prescription worsens during the critical growth years.
The goal of myopia management is not simply to reduce the need for stronger glasses. Higher levels of myopia are associated with increased risk of retinal detachment, glaucoma, cataracts at an earlier age, and myopic macular degeneration. By slowing how much myopia develops during childhood, these treatments may reduce the lifetime risk of these sight-threatening conditions. Even a moderate reduction in final prescription can make a meaningful difference in long-term eye health.
Specialty spectacle lenses for myopia control look like regular glasses but contain advanced optical designs that alter how light focuses on the peripheral retina. Standard glasses correct central vision but may encourage the eye to continue growing longer. Myopia control lenses provide clear central vision while creating a controlled defocus pattern in the periphery that may signal the eye to slow its growth. The child wears them like regular glasses throughout the day.
According to a 2025 peer-reviewed analysis, myopia management spectacle lenses slow progression by 40 to 60 percent. These lenses are an excellent option for younger children, children who are not ready for contact lenses, or families who prefer a non-contact, non-pharmaceutical approach. They require no special cleaning routine beyond normal glasses care. The main consideration is consistent wear, as the slowing effect depends on the child wearing the glasses throughout all waking hours.
Multifocal soft contact lenses designed for myopia control use a center-distance design with concentric zones of different focusing power. The central zone provides clear distance vision, while the surrounding zones create peripheral defocus that may help regulate eye growth. These are daily disposable lenses, meaning a fresh pair is used each day and discarded at night. The child does not sleep in the lenses.
According to the same peer-reviewed research, multifocal soft contact lenses can slow myopia progression by up to 59 percent. This approach is well suited for children who are comfortable with contact lens insertion and removal, typically ages eight and older. Daily disposables are convenient because there is no cleaning routine. They are also a good option for active children who participate in sports, as they provide clear, unobstructed peripheral vision that glasses cannot match.
Orthokeratology, or ortho-K, uses specially designed rigid gas permeable lenses that are worn only during sleep. Overnight, the lenses gently reshape the front surface of the cornea, temporarily flattening it enough to correct the child's nearsightedness. In the morning, the child removes the lenses and sees clearly throughout the day without glasses or contacts. The reshaping effect also alters peripheral light focus in a way that may slow eye elongation.
According to the same analysis, orthokeratology slows myopia progression by 32 to 63 percent. Ortho-K offers the unique advantage of providing clear daytime vision without any correction during the day, which appeals to children who play sports or dislike wearing glasses. The treatment requires a detailed fitting process using corneal topography and consistent lens hygiene. Parents typically manage the insertion and removal routine for younger children. Regular follow-up visits are essential to monitor corneal health and ensure the lenses are performing correctly.
Low-dose atropine eye drops are administered once daily, usually at bedtime. Atropine acts on receptors in the eye that influence the signaling pathways involved in eye growth. At the low concentrations used for myopia management, the drops slow the rate at which the eyeball elongates without significantly affecting the child's pupil size or near focus. The drops do not correct the existing myopia. The child still wears their regular glasses or contacts for clear vision.
According to the same peer-reviewed analysis, low-dose atropine slows myopia progression by 50 to 60 percent. Atropine is the simplest treatment to administer, requiring only one drop per eye each night. This makes it especially practical for younger children who are not yet ready for contact lens wear. The drops are prepared by a compounding pharmacy at the specific concentration prescribed by your eye doctor. Side effects at low doses are minimal, typically limited to mild light sensitivity that is easily managed with sunglasses.
According to the published research, all four major approaches fall within a similar range of effectiveness, slowing progression by roughly 40 to 60 percent depending on the specific treatment and the individual child. No single option is dramatically more effective than the others across all patients. What differs is the mechanism, the daily routine, and the practical demands on the child and family. Your eye doctor at Insight Vision Optometry, Las Vegas will help you weigh these factors against your child's specific needs and preferences.
For very young children, ages four to seven, atropine drops and myopia control spectacle lenses are often the most practical options because they do not require contact lens handling skills. For children ages eight and older who are comfortable with contacts, multifocal soft lenses and ortho-K become available options. Maturity, motivation, and the ability to follow a hygiene routine all factor into the decision. Your eye doctor will assess your child's readiness during the evaluation.
In some cases, your eye doctor may recommend combining two treatments, such as ortho-K with low-dose atropine or spectacle lenses with atropine. Combination therapy may provide a stronger slowing effect than either treatment alone, particularly for children with rapid progression. The decision to combine treatments is based on how your child responds to the initial approach and whether additional slowing is needed. Families from Henderson, Enterprise, Paradise, Spring Valley, and across the Las Vegas area work with our team to find the right combination for their child.
At Insight Vision Optometry, Las Vegas, the myopia management consultation includes a thorough eye exam, refraction, corneal topography, and axial length measurement. Your eye doctor reviews your child's prescription history, family history, visual habits, and lifestyle. This information helps identify which treatment options are most appropriate and establishes a baseline for tracking progress.
Choosing a myopia management approach is a collaborative process between you, your child, and your eye doctor. Our team explains the pros and considerations of each option in plain language, answers your questions, and helps you select the approach that best fits your family. The plan is flexible and can be adjusted over time as your child grows, as the prescription changes, or as new evidence supports modifications to the strategy.
Once treatment begins, your child will return for regular follow-up visits, typically every three to six months. At each visit, your eye doctor measures the prescription and axial length to determine whether the treatment is providing the expected slowing effect. If the results are on track, the current approach continues. If progression is faster than expected, the plan may be adjusted by changing the treatment, adjusting the dose, or adding a complementary approach.
